NCT07217509View on ClinicalTrials.gov

PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry

Enrolling by invitationOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

December 31, 2099

Study Completion Date

December 31, 2099

Conditions
Myasthenia Gravis
Trial Locations (1)

02451

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

CorEvitas
All Listed Sponsors
lead

CorEvitas

NETWORK